Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Life (Basel, Switzerland)|February 27, 2026
Cystic Fibrosis: A Disease with a New FaceJanice Wang, Patricia A WalkerJournal of Genetic Counseling|April 1, 2020
The CFTR variant profile of Hispanic patients with cystic fibrosis: Impact on access to effective screening, diagnosis, and personalized medicineMegan N Januska, Laura Marx, Patricia A Walker, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 19, 2023
Center-level self-study identifies opportunities to advance equity in cystic fibrosis clinical trial participationMegan N Januska, Elinor Langfelder-Schwind, Amy Plachta, et al.Blood Advances|January 4, 2018
Bortezomib-based antibody depletion for refractory autoimmune hematological diseasesSumita Ratnasingam, Patricia A Walker, Huy Tran, et al.The Lancet. Respiratory Medicine|May 20, 2014
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trialEitan Kerem, Michael W Konstan, Kris De Boeck, et al.Blood|April 8, 2025
Acalabrutinib-Obinutuzumab Improves Survival vs Chemoimmunotherapy in treatment-naive CLL in the 6-year Follow-up of ELEVATE-TNJeff P Sharman, Miklos Egyed, Wojciech Jurczak, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2024
Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIAMazyar Shadman, Talha Munir, Tadeusz Robak, et al.Pageof 1